JAK1 P960X
Gene Variant Detail

Request Content

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Gene JAK1
Variant P960X
Impact List missense
Protein Effect unknown
Gene Variant Descriptions JAK1 P960X indicates any JAK1 missense mutation that results in replacement of the proline (P) at amino acid 960 by a different amino acid.
Associated Drug Resistance
Category Variants Paths

JAK1 mutant JAK1 P960X

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Transcript NM_002227.4
gDNA chr1:g.64838552_64838554
cDNA c.2878_2880
Protein p.P960
Source Database RefSeq
Genome Build GRCh38/hg38
Transcript gDNA cDNA Protein Source Database Genome Build
XM_047419674.1 chr1:g.64838552_64838554 c.2878_2880 p.P960 RefSeq GRCh38/hg38
NM_001321856.2 chr1:g.64838552_64838554 c.2878_2880 p.P960 RefSeq GRCh38/hg38
XM_047419675.1 chr1:g.64838552_64838554 c.2878_2880 p.P960 RefSeq GRCh38/hg38
NM_001321852.2 chr1:g.64838552_64838554 c.2878_2880 p.P960 RefSeq GRCh38/hg38
NM_001321855.2 chr1:g.64838552_64838554 c.2878_2880 p.P960 RefSeq GRCh38/hg38
NM_001321853.2 chr1:g.64838552_64838554 c.2878_2880 p.P960 RefSeq GRCh38/hg38
NM_001321854.2 chr1:g.64838552_64838554 c.2878_2880 p.P960 RefSeq GRCh38/hg38
NM_001320923.2 chr1:g.64838552_64838554 c.2878_2880 p.P960 RefSeq GRCh38/hg38
NM_002227.4 chr1:g.64838552_64838554 c.2878_2880 p.P960 RefSeq GRCh38/hg38

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Clinical Trial Phase Therapies Title Recruitment Status Covered Countries Other Countries
NCT05745714 Phase Ib/II Cyclophosphamide + Cytarabine + Dexamethasone + Ruxolitinib + Venetoclax HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies (HEM-iSMART C) Recruiting SWE | NOR | NLD | ITA | ISR | IRL | GBR | FRA | FIN | ESP | DNK | DEU | BEL | AUT 0